Comp2Comp: Open-Source Software with FDA-Cleared Artificial Intelligence Algorithms for Computed Tomography Image Analysis
Adrit Rao, Malte Jensen, Andrea T. Fisher, Louis Blankemeier, Pauline Berens, Arash Fereydooni, Seth Lirette, Eren Alkan, Felipe C. Kitamura, Juan M. Zambrano Chaves, Eduardo Reis, Arjun Desai, Marc H. Willis, Jason Hom, Andrew Johnston, Leon Lenchik, Robert D. Boutin, Eduardo M. J. M. Farina, Augusto S. Serpa, Marcelo S. Takahashi, Jordan Perchik, Steven A. Rothenberg, Jamie L. Schroeder, Ross Filice, Leonardo K. Bittencourt, Hari Trivedi, Marly van Assen, John Mongan, Kimberly Kallianos, Oliver Aalami, Akshay S. Chaudhari
TL;DR
This work tackles the transparency and validation gap in FDA-cleared AI for opportunistic CT by introducing Comp2Comp, an open-source platform housing two FDA 510(k)-cleared modules, AAQ for abdominal aorta diameter and BMD for vertebral bone density. The authors detail end-to-end pipelines—AAQ with a 3D nnU-Net that crops to L1–L5 and extracts the maximal minor-axis diameter, and BMD with L1–L4 vertebral HU-based calibration to flag low density—validated across four external institutions against radiologist measurements and DXA references, respectively, with strong performance metrics ($MAE=1.58$ mm, $ICC=0.985$, $S=81.0\%,\;SP=78.4\%$, $r=0.791$, AUROC continuous $=0.883$, binary $=0.797$). By making code and model weights openly accessible, the work emphasizes reproducibility and local validation to streamline adoption and support future FDA clearance of open AI tools. The findings suggest meaningful clinical impact for opportunistic AAA detection and osteoporosis risk screening, while acknowledging limitations such as post-endograft performance for AAQ and lack of contrast-enhanced CT validation for BMD. Overall, Comp2Comp advances transparent, open-source AI in radiology and provides a framework for broader, multi-institutional validation and registry-building in body composition analysis.
Abstract
Artificial intelligence allows automatic extraction of imaging biomarkers from already-acquired radiologic images. This paradigm of opportunistic imaging adds value to medical imaging without additional imaging costs or patient radiation exposure. However, many open-source image analysis solutions lack rigorous validation while commercial solutions lack transparency, leading to unexpected failures when deployed. Here, we report development and validation for two of the first fully open-sourced, FDA-510(k)-cleared deep learning pipelines to mitigate both challenges: Abdominal Aortic Quantification (AAQ) and Bone Mineral Density (BMD) estimation are both offered within the Comp2Comp package for opportunistic analysis of computed tomography scans. AAQ segments the abdominal aorta to assess aneurysm size; BMD segments vertebral bodies to estimate trabecular bone density and osteoporosis risk. AAQ-derived maximal aortic diameters were compared against radiologist ground-truth measurements on 258 patient scans enriched for abdominal aortic aneurysms from four external institutions. BMD binary classifications (low vs. normal bone density) were compared against concurrent DXA scan ground truths obtained on 371 patient scans from four external institutions. AAQ had an overall mean absolute error of 1.57 mm (95% CI 1.38-1.80 mm). BMD had a sensitivity of 81.0% (95% CI 74.0-86.8%) and specificity of 78.4% (95% CI 72.3-83.7%). Comp2Comp AAQ and BMD demonstrated sufficient accuracy for clinical use. Open-sourcing these algorithms improves transparency of typically opaque FDA clearance processes, allows hospitals to test the algorithms before cumbersome clinical pilots, and provides researchers with best-in-class methods.
